Previous close | 10.56 |
Open | 10.64 |
Bid | 10.56 x 100 |
Ask | 10.61 x 100 |
Day's range | 10.42 - 10.96 |
52-week range | 4.07 - 12.48 |
Volume | |
Avg. volume | 1,006,965 |
Market cap | 675.59M |
Beta (5Y monthly) | 1.39 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.29 |
Earnings date | 05 Dec 2024 - 09 Dec 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 13.50 |
TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the upcoming Craig-Hallum Bioprocessing Conference. Nick Green, president and chief executive officer, and Pramthesh Patel, Ph.D.,
Avid Bioservices ( NASDAQ:CDMO ) First Quarter 2025 Results Key Financial Results Revenue: US$40.2m (up 6.5% from 1Q...
Q1 2025 Avid Bioservices Inc Earnings Call